MNPR
USDMonopar Therapeutics Inc. Common Stock
实时价格
价格图表
关键指标
市场指标
开盘价
$85.950
最高价
$86.140
最低价
$80.105
成交量
0.14M
公司基本面
市值
510.3M
所属行业
生物技术
国家/地区
United States
交易统计
平均成交量
0.07M
交易所
NCM
货币
USD
52周价格范围
相关新闻
Barclays Initiates Coverage On Monopar Therapeutics with Overweight Rating, Announces Price Target of $125
Barclays analyst Etzer Darout initiates coverage on Monopar Therapeutics with a Overweight rating and announces Price Target of $125.
Raymond James Maintains Strong Buy on Monopar Therapeutics, Raises Price Target to $142
Raymond James analyst Chris Raymond maintains Monopar Therapeutics with a Strong Buy and raises the price target from $80 to $142.
HC Wainwright & Co. Maintains Buy on Monopar Therapeutics, Raises Price Target to $105
HC Wainwright & Co. analyst Andres Y. Maldonado maintains Monopar Therapeutics with a Buy and raises the price target from $70 to $105.
Piper Sandler Maintains Overweight on Monopar Therapeutics, Raises Price Target to $95
Piper Sandler analyst Biren Amin maintains Monopar Therapeutics with a Overweight and raises the price target from $76 to $95.
Chardan Capital Maintains Buy on Monopar Therapeutics, Raises Price Target to $85
Chardan Capital analyst Keay Nakae maintains Monopar Therapeutics with a Buy and raises the price target from $60 to $85.
BTIG Maintains Buy on Monopar Therapeutics, Raises Price Target to $104
BTIG analyst Jeet Mukherjee maintains Monopar Therapeutics with a Buy and raises the price target from $87 to $104.
Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (NASDAQ:MNPR) ("Monopar Therapeutics", "Monopar", or the "Company"), a clinical-stage biopharmaceutical company developing innovative
